Scinovex
Subscribe
M

Mark E. Cooper

Beth Israel Deaconess Medical Center (US)ORCID 0000-0001-7785-2488
h-index
123
Publications
708
Citations
73.5K
i10-index
436
Impact (2-yr)
6.55
Citations per year
Research Areas
Chronic Kidney Disease and DiabetesDiabetes Treatment and ManagementAdvanced Glycation End Products researchBlood Pressure and Hypertension StudiesRenin-Angiotensin System Studies
Affiliations
Université Claude Bernard Lyon 1
FR · 2013–2013
Rutgers, The State University of New Jersey
US · 2022–2022
AstraZeneca (United Kingdom)
GB · 2022–2024
Kurume University
JP · 2004–2004
University of Copenhagen
DK · 2001–2011
Brigham and Women's Hospital
US · 2004–2011
Juvenile Diabetes Research Foundation
CA · 2006–2009
Merck & Co., Inc., Rahway, NJ, USA (United States)
US · 2000–2007

Top Publications

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
New England Journal of Medicine20017,433 citations
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
New England Journal of Medicine20087,365 citations
Mechanisms of Diabetic Complications
Physiological Reviews20132,735 citationsCorresponding
Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes
Diabetes20081,200 citations
Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes
Journal of the American Society of Nephrology2009968 citations
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL
Kidney International2004965 citations
Post-insemination associations between males and females in Diplopoda: A remark on Alcock’s (1994) predictions of the mate-guarding hypothesis
Journal of Entomology and Zoology Studies20165 citationsFirst authorCorresponding
Does sexual size dimorphism vary with hours of sunshine throughout the year in forest millipedes Centrobolus Cook, 1897?
Acta Entomology and Zoology20221 citationsFirst authorCorresponding